| Revenue growth | +19.4% YoY Q2; +27.6% YoY H1 |
|---|---|
| Margins | Gross 27.2% (+239 bps QoQ); Op. EBITDA 8.3% (+30 bps YoY) |
| Demand visibility | Returning customers +27% YoY; 3.1 lakh past buyers |
| Management confidence | Confident on cost-led margin; no quarterly targets |
Growth
Revenue +19.4% YoY to ₹87.10 Cr; H1 +27.6%. PAT +8.8% YoY. Gross margin down 599 bps to 27.2%.
Outlook
No quarterly revenue or profit guidance. Long-term Op. EBITDA margin 13–18%; opex toward ~12% of revenue; inventory days 120–150 in FY27.
Risks
Inventory ₹104.09 Cr (~151 days), up ₹22.93 Cr since March; H1 operating cash flow −₹16.75 Cr; returns up to 5.8%.
Investor Presentation filed with NSE, NSE: DENTALKART. Summary written with AI assistance from the document.
Vasa Denticity Ltd: key numbers
- Share price
- ₹459.60
- Market cap
- ₹763.9 Cr
- Revenue (annual)
- ₹278.9 Cr
- Net profit (annual)
- ₹10.24 Cr
- P/E (TTM)
- 74.6×Sector 54.4×
- Promoter holding
- 59.65%-0.54% QoQ
- FII holding
- 7.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vasa Denticity Ltd
All →Vasa Denticity Earnings Call Transcript: Key Takeaways
Revenue up 19.4% to ₹87.1 Cr; EBITDA ₹7.24 Cr, margin 8.31% vs 8.01%. Margin gain driven by opex cut; gross margin fell ~6 pts amid stock rebuild.
Vasa Denticity Management Change
Vasa Denticity re-appointed Independent Director Varun Chugh for five years, effective November 6, 2026. Shareholder approval at a general meeting is pending.
- Execution
- November 6, 2026 to November 6, 2031
Vasa Denticity Q2 FY27 Results: Net Profit ₹5.2 Cr, Up 8.3% YoY
Vasa Denticity Ltd reported revenue from operations of ₹87.1 Cr (+19.5% YoY) and net profit of ₹5.2 Cr (+8.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.2 Cr · +8.3% YoY
Vasa Denticity Board Meeting Date
VASA Denticity Limited will hold a board meeting on 06-Nov-2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closure is in effect from 01-Oct-2026.
Vasa Denticity Convertible Warrants
Vasa Denticity received NSE trading approval for 1,50,000 shares from preferential warrant conversion. Listed capital rises to ₹17.49 crore, with trading from 02 November 2026.
Vasa Denticity Other Announcement
Vasa Denticity Limited informed that the Corporate Governance Report is not applicable to the company as it is listed on the SME platform.